WntResearch is active in biotechnology. Today the main focus is on the development of drug candidates for various metastatic forms of cancer. The research is focused on studying the bodily-specific protein WNT-5a, which has been found to play a crucial role in the proliferation of tumour cells. The products are licensed to various stakeholders in the industry. The head office is in Malmö.

Quotes for WntResearch AB

Right Now

+/-
0.006
%
1,53%
Latest
0.398
High
0.407
Low
0.392
Volume
88 812
Turnover (SEK)
34 954
Market Value (MSEK)
53,0
Time (Latest trade)

Board

CEO

  • Pernilla Sandwall

Chairperson of the Board

  • Gudrun Anstrén

Board

  • Bengt Gustavsson
  • Jan Nilsson
  • Janna Sand-Dejmek
  • Martin Olovsson
  • Peter Ström
  • Tommy Andersson

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 10,39 10,39 2022-03-31
Linfan Zhang 5,57 5,57 2022-03-31
Nordnet Pensionsförsäkring 4,87 4,87 2022-03-31
Gunvald Berger 1,55 1,55 2022-03-31
Thomas Mellqvist 1,52 1,52 2022-03-31
Kjell Stenberg 1,51 1,51 2022-03-31
Niclas Evertsson 1,46 1,46 2022-03-31
Karl Gustav Wangel 1,29 1,29 2022-03-31
Lars-Erik Forsgårdh 1,19 1,19 2022-03-31
Claes Sjölund 1,14 1,14 2022-03-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2022-06-02 Årsstämma 2021

  • 2022-08-18 Delårsrapport 2022-Q2

  • 2022-11-17 Delårsrapport 2022-Q3